apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer (2018) Schmidkonz C, Cordes M, Beck M, Goetz TI, Schmidt D, Prante O, Bäuerle T, et al. Journal article ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma (2018) Feyerabend S, Boegemann M, Goebell P, Stoeckle M, Nepert D, Wride K, Thomas D, et al. Conference contribution Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-Registry (2018) Goebell P, Staehler M, Mueller L, Nusch A, Scheffler M, Sauer A, Von Verschuer U, et al. Journal article Advanced Prostate Cancer Consensus Conference 2017. Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts (2018) Schostak M, Koenig F, Boegemann M, Goebell P, Hammerer P, Machtens S, Schwentner C, et al. Journal article An Essay on Health Services Research - Contributions from the Urology (2018) Goebell P Journal article, Editorial Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry (2018) Goebell P, Mueller L, Huebner A, Harich HD, Boller E, Koska M, Jaenicke M, Marschner N Journal article SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma (2018) Scheich S, Ahrens M, Goekbuget N, Boleti E, Burkholder , Escudier BJ, Goebell P, et al. Conference contribution SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer (2018) Schmidkonz C, Cordes M, Beck M, Goetz TI, Schmidt D, Prante O, Bäuerle T, et al. Journal article 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer (2018) Schmidkonz C, Cordes M, Schmidt D, Bäuerle T, Goetz TI, Beck M, Prante O, et al. Journal article 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer (2018) Schmidkonz C, Hollweg C, Beck M, Reinfelder J, Götz T, Sanders JC, Schmidt D, et al. Journal article